COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,823 Articles (22,968 medRxiv, 8,855 bioRxiv)

Most recent first Previous |  Page 1852: Articles 18511-18520  | Next

Homologous and heterologous serological response to the N-terminal domain of SARS-CoV-2
Lv, H., Tsang, O. T.-Y., So, R. T. Y., Wang, Y., Liu, H., Yip, G. K., Teo, Q. W., Lin, Y., Liang, W., Wang, J., Ng, W. W., Wilson, I. A., Peiris, M., Wu, N. C., Mok, C. K. P.
10.1101/2021.02.17.431722 — Posted: 2021-02-18
A Combination Adjuvant for the Induction of Potent Antiviral Immune Responses for a Recombinant SARS-CoV-2 Protein Vaccine
Jangra, S., Landers, J. J., Rathnasinghe, R., O'Konek, J. J., Janczak, K. W., Cascalho, M., Kennedy, A. A., Tai, A. W., Baker, J. R., Schotsaert, M., Wong, P. T.
10.1101/2021.02.18.431484 — Posted: 2021-02-18
Alzheimer's-like remodeling of neuronal ryanodine receptor in COVID-19
Marks, A. R., Dridi, H., Reiken, S., Liu, X., Sittenfeld, L.
10.1101/2021.02.18.431811 — Posted: 2021-02-18
Immune characterization and profiles of SARS-CoV-2 infected patients
Policard, M., Jain, S., Rego, S., Dakshanamurthy, S.
10.1101/2021.02.17.431721 — Posted: 2021-02-18
Epidemiology of COVID-19 infection amongst workers in Primary Healthcare in Qatar
Al Kuwari, M., AbdelMalik, M., Al Nuaimi, A., AbdelMajeed, J., Romaihi, H., semaan, s.
10.1101/2021.02.15.21251586 — Posted: 2021-02-18
Severe SARS-CoV-2 infection induces a distinct nasal cytokine profile
Morton, B., Barnes, K., Anscombe, C., Jere, K., Kamng'ona, R., Brown, C., Nyirenda, J., Phiri, T., Banda, N. P., Van der veer, C., Mndolo, K. S., Mponda, K., Rylance, J., Phiri, C., Mallewa, J., Nyirenda, M., Katha, G., Kambiya, P., Jafali, J., Mwandumba, H., Gordon, S., Cornick, J., Jambo, K. C., Blantyre COVID-19 consortium
10.1101/2021.02.15.21251753 — Posted: 2021-02-18
Quantification of the tradeoff between test sensitivity and test frequency in COVID-19 epidemic - a multi-scale modeling approach
Forde, J. E., Ciupe, S. M.
10.1101/2021.02.15.21251791 — Posted: 2021-02-18
Artificial Intelligence Applications for COVID-19 in Intensive Care and Emergency Settings: A Systematic Review
Chee, M. L., Ong, M. E. H., Siddiqui, F. J., Zhang, Z., Lim, S. L., Ho, A. F. W., Liu, N.
10.1101/2021.02.15.21251727 — Posted: 2021-02-18
Circulating SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity
Garcia-Beltran, W. F., Lam, E. C., St. Denis, K., Nitido, A. D., Garcia, Z. H., Hauser, B. M., Feldman, J., Pavlovic, M. N., Gregory, D. J., Poznansky, M. C., Sigal, A., Schmidt, A. G., Iafrate, A. J., Naranbhai, V., Balazs, A. B.
10.1101/2021.02.14.21251704 — Posted: 2021-02-18
FDA-authorized COVID-19 vaccines are effective per real-world evidence synthesized across a multi-state health system
Pawlowski, C., Lenehan, P., Puranik, A., Agarwal, V., Venkatakrishnan, A., Niesen, M. J., O Horo, J. C., Badley, A. D., Halamka, J., Soundararajan, V.
10.1101/2021.02.15.21251623 — Posted: 2021-02-18 Discussion: Onsite | Offsite

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).